Ewing sarcoma of the cervix: an unusual site of presentation

Ewing sarcoma is an exceedingly rare form of cancer that affects the cervix. It falls within the spectrum of neoplastic diseases known as Ewing's family of tumours, typically observed in osseous tissues. A woman in her 40s, experiencing symptoms of leucorrhoea and transvaginal bleeding that com...

Full description

Saved in:
Bibliographic Details
Published inBMJ case reports Vol. 17; no. 3; p. e257912
Main Authors Hernández-García, Jesús Guillermo, Pinto García, Luis José, Marché Fernández, Osvaldo Alexis, Diaz-Garcia, Juan Daniel
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 21.03.2024
Subjects
Biopsy
Cancer therapies
Case reports
Cervical cancer
Cervix
Cervix Uteri - pathology
Chemotherapy
Ewings sarcoma
Female
Gynecological cancer
Gynecology
Humans
Medical imaging
Oncology
Radiation therapy
Sarcoma, Ewing - diagnostic imaging
Sarcoma, Ewing - therapy
Tumors
Ultrasonic imaging
Urination
Uterus
Vagina
Mexico
Chemotherapy
Cervical cancer
Gynecological cancer
Online AccessGet full text

Cover

More Information
Summary:Ewing sarcoma is an exceedingly rare form of cancer that affects the cervix. It falls within the spectrum of neoplastic diseases known as Ewing's family of tumours, typically observed in osseous tissues. A woman in her 40s, experiencing symptoms of leucorrhoea and transvaginal bleeding that commenced 3 months before her consultation, was referred to our gynaecological oncology clinic with a preliminary diagnosis of ovarian teratoma. A colposcopy procedure was conducted unveiling a complete loss of cervical anatomy with friable and malodorous tissue. Pelvic ultrasound identified a lesion of uncertain origin in the cervix, suggestive of malignancy. Histopathological assessment of cervical biopsy specimens confirmed the presence of a small, round, blue cell neoplasm consistent with Ewing sarcoma. She underwent chemotherapy and pelvic radiotherapy, achieving complete remission 9 months after diagnosis, without experiencing any systemic adverse effects or sequelae.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1757-790X
1757-790X
DOI:10.1136/bcr-2023-257912